\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ facial\\ numbness\\ and\\ slurring\\ of\\ speech\ \(0\)\
\-\ the\\ primary\\ medications\\ used\\ post\\-stroke\\ are\\ aspirin\\,\\ coumadin\\,\\ and\\ clopidogrel\\ for\\ stroke\\ prophylaxis\\.\\ \\ \\ depending\\ on\\ the\\ severity\\ and\\ origin\\ of\\ the\\ stroke\\,\\ carotid\\ endartarectomy\\,\\ angioplasty\\ and\\ intralumenal\\ stents\\,\\ or\\ extracranial\\-intracranial\\ bypass\\ may\\ be\\ considered\\.\ \(0\)\
\-\ mri\\â\\€\\“brain\\:\\ diffusion\\-weighted\\ images\\ \\â\\€\\“\\ increased\\ signal\\ intensity\\ involving\\ l\\ insular\\ cortex\\ and\\ adjacent\\ operculum\\.\\ \\ flair\\ and\\ t2\\-weighted\\ images\\ \\â\\€\\“\\ increased\\ signal\\ intensity\\ throughout\\ l\\ corona\\ radiate\\ w\\/\\ volume\\ loss\\ of\\ the\\ l\\ frontal\\ and\\ parietal\\ lobes\\.\\ \\ large\\ wedge\\-shaped\\ region\\ of\\ encephalomalacia\\ in\\ the\\ lateral\\ r\\ frontal\\ lobe\\ possibly\\ secondary\\ to\\ prior\\ infarct\\.\\ \ \(0\)\
\-\ mra\\-brain\\:\\ severe\\ near\\ occlusion\\ of\\ icas\\ bilaterally\\,\\ normal\\ appearance\\ of\\ vertebral\\ and\\ basilar\\ arteries\\.\\ \\ \ \(0\)\
\-\ dopper\\ u\\/s\\-carotids\\:\\ r\\ ica\\ completely\\ occluded\\ within\\ a\\ centimeter\\ past\\ bifurcation\\,\\ l\\ ica\\ \\â\\€\\“\\ very\\ high\\ resistance\\,\\ abnormal\\ flow\\ at\\ origin\\,\\ possibly\\ due\\ to\\ clot\\ or\\ very\\,\\ very\\ slow\\ flow\\ just\\ above\\ bifurcation\ \(0\)\
\-\ cerebral\\ infarct\\ \\(l\\ mca\\ territory\\)\ \(0\)\
\-\ cerebral\\ infarct\\ \\(l\\ mca\\ territory\\)\\,\\ tia\\,\\ common\\ neurologic\\ deficits\\ after\\ \\(old\\)\\ stroke\ \(0\)\
\-\ 36\\ y\\.o\\.\\ african\\-american\\ female\\ with\\ sickle\\ cell\\ anemia\ \(0\)\
\-\ cerebral\\ infarcts\\ \\(strokes\\)\\ are\\ either\\ ischemic\\ or\\ hemorrhagic\\ in\\ origin\\.\\ \\ ischemia\\ is\\ responsible\\ for\\ two\\-thirds\\ of\\ strokes\\,\\ while\\ hemorrhage\\ causes\\ about\\ one\\-third\\.\\ \\ ct\\ or\\ mri\\ provide\\ a\\ more\\ definitive\\ diagnosis\\ than\\ simply\\ the\\ history\\ or\\ clinical\\ symptoms\\.\\ \\ \ \(0\)\
\-\ \\ \\ \\ ischemic\\ strokes\\ can\\ be\\ caused\\ by\\ thrombosis\\ or\\ embolism\\.\\ \\ thrombosis\\ more\\ commonly\\ occludes\\ larger\\ cerebral\\ arteries\\,\\ such\\ as\\ the\\ icas\\,\\ mca\\ or\\ basilar\\ artery\\,\\ or\\ the\\ venous\\ system\\.\\ \\ these\\ are\\ generally\\ preceded\\ by\\ tias\\,\\ which\\ give\\ warning\\ of\\ an\\ impending\\ stroke\\ and\\ its\\ affected\\ territory\\.\\ \\ the\\ symptoms\\ generally\\ progress\\ over\\ minutes\\ to\\ hours\\.\\ \\ embolism\\ usually\\ occurs\\ when\\ thrombi\\ pass\\ to\\ distal\\ cerebral\\ arteries\\ from\\ larger\\ vessels\\ such\\ as\\ the\\ heart\\,\\ aorta\\,\\ or\\ large\\ cerebral\\ arteries\\.\\ \\ the\\ symptoms\\ at\\ presentation\\ usually\\ do\\ not\\ progress\\ further\\.\\ \\ \\ hemorrhagic\\ strokes\\ can\\ result\\ in\\ destruction\\ or\\ compression\\ of\\ brain\\ tissue\\ or\\ vessels\\ that\\ then\\ cause\\ neurologic\\ symptoms\\.\\ \\ some\\ common\\ causes\\ are\\ intracerebral\\ hemorrhage\\,\\ subarachnoid\\ hemorrhage\\,\\ or\\ subdural\\ or\\ epidural\\ hemorrhage\\.\\ \ \(0\)\
\-\ \\ \\ \\ a\\ patient\\ who\\ suffers\\ from\\ a\\ cerebral\\ infarct\\ often\\ has\\ co\\-morbid\\ conditions\\,\\ broadly\\ broken\\ down\\ into\\ vascular\\,\\ cardiac\\ and\\ hematologic\\ disorders\\.\\ \\ common\\ vascular\\ disorders\\ are\\ atherosclerosis\\,\\ inflammatory\\ disorders\\ \\(e\\.g\\.\\,\\ sle\\,\\ temporal\\ arteritis\\)\\ and\\ migraines\\.\\ \\ arrhythmias\\,\\ endocarditis\\,\\ and\\ rheumatic\\ heart\\ disease\\ can\\ lead\\ to\\ strokes\\.\\ \\ like\\ this\\ patient\\,\\ sickle\\ cell\\ disease\\ and\\ hypercoagulable\\ states\\ can\\ also\\ result\\ in\\ strokes\\.\ \(0\)\
\-\ \\ \\ \\ the\\ middle\\ cerebral\\ artery\\ is\\ the\\ most\\ commonly\\ occluded\\ vessel\\ in\\ an\\ ischemic\\ stroke\\.\\ \\ a\\ stroke\\ of\\ the\\ superior\\ division\\ will\\ result\\ in\\ contralateral\\ hemiparesis\\ affecting\\ the\\ upper\\ body\\ \\(but\\ not\\ the\\ legs\\)\\,\\ contralateral\\ hemisensory\\ deficit\\ and\\ if\\ the\\ dominant\\ hemisphere\\ is\\ involved\\,\\ broca\\â\\€\\™s\\ aphasia\\.\\ \\ an\\ inferior\\ division\\ stroke\\ may\\ result\\ in\\ cortical\\ sensory\\ function\\ impairment\\ such\\ as\\ contralateral\\ graphesthesia\\ and\\ stereognosis\\ and\\ disorders\\ of\\ spatial\\ thought\\.\\ \\ in\\ the\\ dominant\\ hemisphere\\,\\ wernicke\\â\\€\\™s\\ aphasia\\ may\\ occur\\.\\ \\ a\\ stroke\\ at\\ the\\ bifurcation\\ or\\ trifurcation\\ will\\ have\\ superior\\ and\\ inferior\\ divisional\\ symptoms\\,\\ plus\\ homonymous\\ hemianopia\\ and\\ global\\ aphasia\\.\\ \\ finally\\,\\ an\\ occlusion\\ of\\ the\\ stem\\ of\\ the\\ mca\\ will\\ logically\\ be\\ the\\ most\\ devastating\\,\\ as\\ it\\ can\\ cause\\ hemiparesis\\ of\\ the\\ entire\\ contralateral\\ side\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stroke\\:\\ 0\\.31504397286772406\ \(0\)\
\-\ strokes\\:\\ 0\\.2936863464069859\ \(0\)\
\-\ cerebral\\:\\ 0\\.20862670189065713\ \(0\)\
\-\ or\\:\\ 0\\.18332703174338374\ \(0\)\
\-\ the\\:\\ 0\\.172749134386236\ \(0\)\
\-\ mca\\:\\ 0\\.15582573747865563\ \(0\)\
\-\ contralateral\\:\\ 0\\.150577100762161\ \(0\)\
\-\ and\\:\\ 0\\.14000658271268807\ \(0\)\
\-\ territory\\:\\ 0\\.13312154120459366\ \(0\)\
\-\ disorders\\:\\ 0\\.1329387583362732\ \(0\)\
\-\ aphasia\\:\\ 0\\.12570406080529398\ \(0\)\
\-\ infarct\\:\\ 0\\.1252900427151405\ \(0\)\
\-\ bifurcation\\:\\ 0\\.12178787658639688\ \(0\)\
\-\ arteries\\:\\ 0\\.11949999582758919\ \(0\)\
\-\ result\\:\\ 0\\.11271888641146144\ \(0\)\
\-\ icas\\:\\ 0\\.10589487775596021\ \(0\)\
\-\ of\\:\\ 0\\.10312769473740054\ \(0\)\
\-\ symptoms\\:\\ 0\\.10297632844321129\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.10080756411997037\ \(0\)\
\-\ ischemic\\:\\ 0\\.09987112569666518\ \(0\)\
\-\ can\\:\\ 0\\.09876518563871006\ \(0\)\
\-\ origin\\:\\ 0\\.09720676145298814\ \(0\)\
\-\ division\\:\\ 0\\.09295046186946218\ \(0\)\
\-\ occluded\\:\\ 0\\.08556497711414587\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.08300261858938578\ \(0\)\
\-\ very\\:\\ 0\\.0810073835501769\ \(0\)\
\-\ ica\\:\\ 0\\.07872946444792085\ \(0\)\
\-\ progress\\:\\ 0\\.07665502023836214\ \(0\)\
\-\ in\\:\\ 0\\.07491175644723783\ \(0\)\
\-\ sickle\\:\\ 0\\.07445033727159868\ \(0\)\
\-\ will\\:\\ 0\\.07268112055310245\ \(0\)\
\-\ such\\:\\ 0\\.0726386851018309\ \(0\)\
\-\ are\\:\\ 0\\.07141607967824057\ \(0\)\
\-\ basilar\\:\\ 0\\.0712241838295838\ \(0\)\
\-\ possibly\\:\\ 0\\.0707555871388476\ \(0\)\
\-\ dominant\\:\\ 0\\.07045218480453003\ \(0\)\
\-\ hemisphere\\:\\ 0\\.07045218480453003\ \(0\)\
\-\ brain\\:\\ 0\\.07039672965165612\ \(0\)\
\-\ occlusion\\:\\ 0\\.0691670970363261\ \(0\)\
\-\ embolism\\:\\ 0\\.06824750183776657\ \(0\)\
\-\ larger\\:\\ 0\\.06738783108950117\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.06530258260566582\ \(0\)\
\-\ common\\:\\ 0\\.06404103007456309\ \(0\)\
\-\ generally\\:\\ 0\\.06377072937746024\ \(0\)\
\-\ thrombosis\\:\\ 0\\.06137962931807864\ \(0\)\
\-\ as\\:\\ 0\\.06048761526427531\ \(0\)\
\-\ endartarectomy\\:\\ 0\\.06019686293363039\ \(0\)\
\-\ intralumenal\\:\\ 0\\.06019686293363039\ \(0\)\
\-\ dopper\\:\\ 0\\.06019686293363039\ \(0\)\
\-\ stereognosis\\:\\ 0\\.06019686293363039\ \(0\)\
\-\ divisional\\:\\ 0\\.06019686293363039\ \(0\)\
\-\ devastating\\:\\ 0\\.06019686293363039\ \(0\)\
\-\ neurologic\\:\\ 0\\.060156104426295855\ \(0\)\
\-\ vessels\\:\\ 0\\.05841963593209254\ \(0\)\
\-\ an\\:\\ 0\\.057575846770380176\ \(0\)\
\-\ slurring\\:\\ 0\\.05752131621094654\ \(0\)\
\-\ warning\\:\\ 0\\.05752131621094654\ \(0\)\
\-\ broca\\:\\ 0\\.05752131621094654\ \(0\)\
\-\ graphesthesia\\:\\ 0\\.05752131621094654\ \(0\)\
\-\ logically\\:\\ 0\\.05752131621094654\ \(0\)\
\-\ causes\\:\\ 0\\.05688530640773713\ \(0\)\
\-\ may\\:\\ 0\\.05682708404568021\ \(0\)\
\-\ commonly\\:\\ 0\\.05570572304521477\ \(0\)\
\-\ clopidogrel\\:\\ 0\\.055622985600663956\ \(0\)\
\-\ broadly\\:\\ 0\\.055622985600663956\ \(0\)\
\-\ hemisensory\\:\\ 0\\.055622985600663956\ \(0\)\
\-\ hemianopia\\:\\ 0\\.055622985600663956\ \(0\)\
\-\ occludes\\:\\ 0\\.05415052598461359\ \(0\)\
\-\ trifurcation\\:\\ 0\\.05415052598461359\ \(0\)\
\-\ intensity\\:\\ 0\\.05345583048713719\ \(0\)\
\-\ operculum\\:\\ 0\\.052947438877980105\ \(0\)\
\-\ impending\\:\\ 0\\.052947438877980105\ \(0\)\
\-\ hematologic\\:\\ 0\\.052947438877980105\ \(0\)\
\-\ heart\\:\\ 0\\.0523454829889346\ \(0\)\
\-\ preceded\\:\\ 0\\.05193024322300581\ \(0\)\
\-\ spatial\\:\\ 0\\.05193024322300581\ \(0\)\
\-\ wernicke\\:\\ 0\\.05193024322300581\ \(0\)\
\-\ cause\\:\\ 0\\.05128620045012225\ \(0\)\
\-\ inferior\\:\\ 0\\.05121618744617699\ \(0\)\
\-\ corona\\:\\ 0\\.05104910826769753\ \(0\)\
\-\ tias\\:\\ 0\\.05104910826769753\ \(0\)\
\-\ migraines\\:\\ 0\\.05027189215529625\ \(0\)\
\-\ arrhythmias\\:\\ 0\\.05027189215529625\ \(0\)\
\-\ rheumatic\\:\\ 0\\.05027189215529625\ \(0\)\
\-\ flow\\:\\ 0\\.05014372595507124\ \(0\)\
\-\ vascular\\:\\ 0\\.04970060547107223\ \(0\)\
\-\ thrombi\\:\\ 0\\.049576648651647154\ \(0\)\
\-\ homonymous\\:\\ 0\\.049576648651647154\ \(0\)\
\-\ insular\\:\\ 0\\.048947724401164315\ \(0\)\
\-\ suffers\\:\\ 0\\.048947724401164315\ \(0\)\
\-\ superior\\:\\ 0\\.04894453275195455\ \(0\)\
\-\ frontal\\:\\ 0\\.04845408036873498\ \(0\)\
\-\ hypercoagulable\\:\\ 0\\.04837356154501367\ \(0\)\
\-\ usually\\:\\ 0\\.04739336681111664\ \(0\)\
\-\ radiate\\:\\ 0\\.04735636589003937\ \(0\)\
\-\ to\\:\\ 0\\.04705143484438082\ \(0\)\
\-\ encephalomalacia\\:\\ 0\\.046901101928963296\ \(0\)\
\-\ artery\\:\\ 0\\.04675568623897148\ \(0\)\
\-\ stents\\:\\ 0\\.04647523093473109\ \(0\)\
\-\ intracerebral\\:\\ 0\\.04647523093473109\ \(0\)\
\-\ broken\\:\\ 0\\.04647523093473109\ \(0\)\
\-\ simply\\:\\ 0\\.046075186627659324\ \(0\)\
\-\ plus\\:\\ 0\\.046075186627659324\ \(0\)\
\-\ be\\:\\ 0\\.045808886575470435\ \(0\)\
\-\ tia\\:\\ 0\\.045341240900772746\ \(0\)\
\-\ give\\:\\ 0\\.04468081916735551\ \(0\)\
\-\ endocarditis\\:\\ 0\\.04468081916735551\ \(0\)\
\-\ resistance\\:\\ 0\\.04437384706819788\ \(0\)\
\-\ centimeter\\:\\ 0\\.04379968421204723\ \(0\)\
\-\ arteritis\\:\\ 0\\.043530311702630345\ \(0\)\
\-\ global\\:\\ 0\\.043530311702630345\ \(0\)\
\-\ aspirin\\:\\ 0\\.043271505584816156\ \(0\)\
\-\ cell\\:\\ 0\\.043065279982596814\ \(0\)\
\-\ responsible\\:\\ 0\\.04302246809964596\ \(0\)\
\-\ signal\\:\\ 0\\.042675728403964455\ \(0\)\
\-\ at\\:\\ 0\\.042652949363864115\ \(0\)\
\-\ angioplasty\\:\\ 0\\.04255093110900111\ \(0\)\
\-\ coumadin\\:\\ 0\\.04190135360176466\ \(0\)\
\-\ atherosclerosis\\:\\ 0\\.04169830034551402\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.04150130929469289\ \(0\)\
\-\ more\\:\\ 0\\.041338357170045845\ \(0\)\
\-\ bypass\\:\\ 0\\.041310028941022564\ \(0\)\
\-\ increased\\:\\ 0\\.0407094056693495\ \(0\)\
\-\ finally\\:\\ 0\\.04059595886213229\ \(0\)\
\-\ impairment\\:\\ 0\\.04010694183438908\ \(0\)\
\-\ sle\\:\\ 0\\.039951670902390234\ \(0\)\
\-\ stem\\:\\ 0\\.03979996973523144\ \(0\)\
\-\ clot\\:\\ 0\\.039225806879080796\ \(0\)\
\-\ most\\:\\ 0\\.03917949420595875\ \(0\)\
\-\ speech\\:\\ 0\\.03882576257200903\ \(0\)\
\-\ pass\\:\\ 0\\.03882576257200903\ \(0\)\
\-\ mri\\:\\ 0\\.038643554462997325\ \(0\)\
\-\ provide\\:\\ 0\\.03809181684512246\ \(0\)\
\-\ affecting\\:\\ 0\\.03786425256518816\ \(0\)\
\-\ large\\:\\ 0\\.03772046355056589\ \(0\)\
\-\ severity\\:\\ 0\\.037124423012547585\ \(0\)\
\-\ legs\\:\\ 0\\.03702519241860931\ \(0\)\
\-\ subdural\\:\\ 0\\.03692743196172645\ \(0\)\
\-\ infarcts\\:\\ 0\\.03683109871586806\ \(0\)\
\-\ slow\\:\\ 0\\.03628088764698005\ \(0\)\
\-\ depending\\:\\ 0\\.03585501665274785\ \(0\)\
\-\ minutes\\:\\ 0\\.0356120919147919\ \(0\)\
\-\ deficit\\:\\ 0\\.0356120919147919\ \(0\)\
\-\ sensory\\:\\ 0\\.03545497234567608\ \(0\)\
\-\ images\\:\\ 0\\.03482334743727156\ \(0\)\
\-\ anemia\\:\\ 0\\.03458354851816305\ \(0\)\
\-\ definitive\\:\\ 0\\.03438255703669747\ \(0\)\
\-\ conditions\\:\\ 0\\.03438255703669747\ \(0\)\
\-\ destruction\\:\\ 0\\.034316897687541564\ \(0\)\
\-\ entire\\:\\ 0\\.034251885239042594\ \(0\)\
\-\ epidural\\:\\ 0\\.034187507068445394\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.03387471343371309\ \(0\)\
\-\ completely\\:\\ 0\\.033634733891140065\ \(0\)\
\-\ lead\\:\\ 0\\.03351793951215602\ \(0\)\
\-\ numbness\\:\\ 0\\.033460308489535115\ \(0\)\
\-\ volume\\:\\ 0\\.03307039785757381\ \(0\)\
\-\ states\\:\\ 0\\.03307039785757381\ \(0\)\
\-\ vessel\\:\\ 0\\.033016530536835\ \(0\)\
\-\ ischemia\\:\\ 0\\.03260072622669994\ \(0\)\
\-\ thought\\:\\ 0\\.03250074385718171\ \(0\)\
\-\ deficits\\:\\ 0\\.03235355462876002\ \(0\)\
\-\ flair\\:\\ 0\\.03202236705235007\ \(0\)\
\-\ by\\:\\ 0\\.03196948014366571\ \(0\)\
\-\ carotid\\:\\ 0\\.031707010314013614\ \(0\)\
\-\ disease\\:\\ 0\\.031601081628182745\ \(0\)\
\-\ medications\\:\\ 0\\.031576338516358736\ \(0\)\
\-\ lobes\\:\\ 0\\.03140603977065478\ \(0\)\
\-\ do\\:\\ 0\\.031199166711029225\ \(0\)\
\-\ 36\\:\\ 0\\.031158559135827043\ \(0\)\
\-\ either\\:\\ 0\\.031118199926552428\ \(0\)\
\-\ facial\\:\\ 0\\.031038214581825468\ \(0\)\
\-\ affected\\:\\ 0\\.030959187168456206\ \(0\)\
\-\ is\\:\\ 0\\.03092509522453296\ \(0\)\
\-\ cortex\\:\\ 0\\.030652215069298574\ \(0\)\
\-\ near\\:\\ 0\\.030652215069298574\ \(0\)\
\-\ aorta\\:\\ 0\\.030577652579400226\ \(0\)\
\-\ down\\:\\ 0\\.030577652579400226\ \(0\)\
\-\ function\\:\\ 0\\.030467365162925416\ \(0\)\
\-\ parietal\\:\\ 0\\.03039485113488995\ \(0\)\
\-\ caused\\:\\ 0\\.030181971056054926\ \(0\)\
\-\ involved\\:\\ 0\\.030181971056054926\ \(0\)\
\-\ just\\:\\ 0\\.0301125103078777\ \(0\)\
\-\ from\\:\\ 0\\.02989917115832331\ \(0\)\
\-\ not\\:\\ 0\\.02971989309969779\ \(0\)\
\-\ occurs\\:\\ 0\\.02967800790607616\ \(0\)\
\-\ considered\\:\\ 0\\.029331456620406992\ \(0\)\
\-\ temporal\\:\\ 0\\.02891518375171561\ \(0\)\
\-\ vertebral\\:\\ 0\\.02874451794197718\ \(0\)\
\-\ system\\:\\ 0\\.02871649789925529\ \(0\)\
\-\ hours\\:\\ 0\\.028688596334869094\ \(0\)\
\-\ used\\:\\ 0\\.02817972160286536\ \(0\)\
\-\ about\\:\\ 0\\.02817972160286536\ \(0\)\
\-\ like\\:\\ 0\\.027976668346614716\ \(0\)\
\-\ cardiac\\:\\ 0\\.027951720452452172\ \(0\)\
\-\ its\\:\\ 0\\.027852861522607384\ \(0\)\
\-\ throughout\\:\\ 0\\.02768334404993519\ \(0\)\
\-\ occur\\:\\ 0\\.02768334404993519\ \(0\)\
\-\ compression\\:\\ 0\\.02756487210385277\ \(0\)\
\-\ above\\:\\ 0\\.02715516542270411\ \(0\)\
\-\ cortical\\:\\ 0\\.027024060908557003\ \(0\)\
\-\ middle\\:\\ 0\\.02691676244450268\ \(0\)\
\-\ venous\\:\\ 0\\.026874326863232992\ \(0\)\
\-\ then\\:\\ 0\\.026645687261835242\ \(0\)\
\-\ involving\\:\\ 0\\.02636569998407154\ \(0\)\
\-\ side\\:\\ 0\\.026003775246433797\ \(0\)\
\-\ presentation\\:\\ 0\\.025911741534948664\ \(0\)\
\-\ inflammatory\\:\\ 0\\.02545282279108965\ \(0\)\
\-\ bilaterally\\:\\ 0\\.02510413057310973\ \(0\)\
\-\ body\\:\\ 0\\.024772942996699777\ \(0\)\
\-\ often\\:\\ 0\\.024561039600219305\ \(0\)\
\-\ further\\:\\ 0\\.02451650370464479\ \(0\)\
\-\ past\\:\\ 0\\.024501724952339824\ \(0\)\
\-\ patient\\:\\ 0\\.024485743940488337\ \(0\)\
\-\ adjacent\\:\\ 0\\.024399190212247745\ \(0\)\
\-\ while\\:\\ 0\\.02432691446070845\ \(0\)\
\-\ clinical\\:\\ 0\\.0238553774700636\ \(0\)\
\-\ severe\\:\\ 0\\.023828662007880485\ \(0\)\
\-\ some\\:\\ 0\\.023683629573119404\ \(0\)\
\-\ primary\\:\\ 0\\.02314542707923966\ \(0\)\
\-\ loss\\:\\ 0\\.022932547000404632\ \(0\)\
\-\ for\\:\\ 0\\.022817665357629507\ \(0\)\
\-\ when\\:\\ 0\\.02273761002279726\ \(0\)\
\-\ appearance\\:\\ 0\\.022692567457831617\ \(0\)\
\-\ abnormal\\:\\ 0\\.022614475302085053\ \(0\)\
\-\ region\\:\\ 0\\.02251541023662817\ \(0\)\
\-\ secondary\\:\\ 0\\.022311032868775636\ \(0\)\
\-\ distal\\:\\ 0\\.021870614156133856\ \(0\)\
\-\ if\\:\\ 0\\.021870614156133856\ \(0\)\
\-\ lobe\\:\\ 0\\.021752776915014743\ \(0\)\
\-\ due\\:\\ 0\\.021637007100918385\ \(0\)\
\-\ high\\:\\ 0\\.0213929302529384\ \(0\)\
\-\ than\\:\\ 0\\.021337864201982228\ \(0\)\
\-\ who\\:\\ 0\\.021292324268673557\ \(0\)\
\-\ these\\:\\ 0\\.021256117263452726\ \(0\)\
\-\ prior\\:\\ 0\\.02106045384077641\ \(0\)\
\-\ over\\:\\ 0\\.020930297547215062\ \(0\)\
\-\ upper\\:\\ 0\\.02011500452508687\ \(0\)\
\-\ into\\:\\ 0\\.020009543442397644\ \(0\)\
\-\ tissue\\:\\ 0\\.019745852902594802\ \(0\)\
\-\ diagnosis\\:\\ 0\\.019513057585168993\ \(0\)\
\-\ it\\:\\ 0\\.019268128886025634\ \(0\)\
\-\ have\\:\\ 0\\.018803965786519303\ \(0\)\
\-\ lateral\\:\\ 0\\.018680621818763406\ \(0\)\
\-\ but\\:\\ 0\\.01861375269599591\ \(0\)\
\-\ after\\:\\ 0\\.01826048135910404\ \(0\)\
\-\ female\\:\\ 0\\.018163732689830823\ \(0\)\
\-\ also\\:\\ 0\\.017705456306814322\ \(0\)\
\-\ within\\:\\ 0\\.017336488209320846\ \(0\)\
\-\ has\\:\\ 0\\.017193514671402486\ \(0\)\
\-\ which\\:\\ 0\\.017115938934204915\ \(0\)\
\-\ that\\:\\ 0\\.016334974923530837\ \(0\)\
\-\ normal\\:\\ 0\\.015368749038711918\ \(0\)\
\-\ history\\:\\ 0\\.014381210557910543\ \(0\)\
\-\ ct\\:\\ 0\\.014330450998801215\ \(0\)\
\-\ this\\:\\ 0\\.01293427789882383\ \(0\)\
\-\ right\\:\\ 0\\.01247969601022197\ \(0\)\
\-\ on\\:\\ 0\\.011368362081880676\ \(0\)\
\-\ old\\:\\ 0\\.01114035331887849\ \(0\)\
\-\ with\\:\\ 0\\.007370665250745155\ \(0\)\
